Immunopathologic studies classify lymphoma under the T-cell or B-cell groups. Such a classification gives a better indication for prognosis and treatment of lymphomas, with the T-cell group having the worse prognosis.
A patient with a T-cell lymphoma of the oral cavity is presented. The diagnostic features and management are discussed.
Get full access to this article
View all access options for this article.
References
1.
WangCC: Primary malignant lymphoma of the oral cavity and paranasal sinuses. Radiology100: 151–153, 1971.
2.
BaileyBJBrindleyPC: Manifestations of malignant lymphomas of the head and neck. Trans Am Acad Ophthalmol Otolaryngol74: 283–290, 1970.
3.
McNelisFLPaiVT: Malignant lymphoma of the head and neck. Laryngoscope79: 1079–1087, 1969.
4.
LuetjeCEricksonC: Current management of non-Hodgkin malignant lymphoma of the head and neck. Arch Otolaryngol101: 11–14, 1975.
5.
SchnitzerBWeaverDK: Batsakis Tumors of the Head and Neck, ed 2. Baltimore, Williams & Wilkins Co, 1979, pp 346–381.
6.
LukesRJCollinsRD: Lukes-Collins classification and its significance. Cancer Treat Rep61: 971–979, 1977.
7.
RappaportH: In discussion II: Round table discussion of histopathologic classification. Cancer Treat Rep61: 1037–1048, 1977.
8.
WhitesideTLRowlandsDTJr: T-cell and B-cell identification in the diagnosis of lymphoproliferative disease. Am J Pathol88: 753–790, 1977.
